# Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers

> **NCT00823446** · PHASE1 · COMPLETED · sponsor: **Revalesio Corporation** · enrollment: 13 (actual)

## Conditions studied

- Venous Stasis Ulcers

## Interventions

- **DEVICE:** Revera Wound Care
- **DEVICE:** Normal Saline

## Key facts

- **NCT ID:** NCT00823446
- **Lead sponsor:** Revalesio Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00823446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00823446, "Feasibility Study to Evaluate the Safety of Topically Applied Revera in Subjects With Venous Leg Ulcers". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00823446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*